Valuation Core Laboratories Inc. Deutsche Boerse AG
Stocks
HJ1
US21867A1051
Business Support Services
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.75 EUR | -3.15% |
|
-7.96% | -23.53% |
| 04-30 | Core Laboratories Inc., Q1 2026 Earnings Call, Apr 30, 2026 | |
| 04-30 | Earnings Flash (CLB) Core Laboratories Inc. Reports Q1 Revenue $121.8M, vs. FactSet Est of $123.0M | MT |
Company Valuation: Core Laboratories Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,033 | 939.9 | 825.1 | 812.7 | 746.4 | 586.3 | - |
| Change | - | -8.98% | -12.21% | -1.51% | -8.16% | -21.44% | - |
| Enterprise Value (EV) | 1,204 | 1,097 | 973.2 | 919.7 | 746.4 | 586.3 | 586.3 |
| Change | - | -8.87% | -11.28% | -5.5% | -18.84% | -21.44% | 0% |
| P/E Ratio | 53.1x | 48.3x | 20.5x | 26.2x | 23.6x | 27.7x | 15.7x |
| PBR | 6.47x | 5.02x | - | - | - | - | - |
| PEG | - | - | 0x | -1.1x | 7.79x | -0.9x | 0.2x |
| Capitalization / Revenue | 2.2x | 1.92x | 1.62x | 1.55x | 1.42x | 1.13x | 1.07x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.13x | 1.07x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 9.78x | 7.03x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 13.1x | 9.86x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.04 | 0.04 | 0.04 | 0.04 | - | 0.04 | 0.04 |
| Rate of return | 0.18% | 0.2% | 0.23% | 0.23% | - | 0.31% | 0.31% |
| EPS 2 | 0.42 | 0.42 | 0.86 | 0.66 | 0.68 | 0.46 | 0.81 |
| Distribution rate | 9.52% | 9.52% | 4.65% | 6.06% | - | 8.7% | 4.94% |
| Net sales 1 | 470.3 | 489.7 | 509.8 | 523.8 | 526.5 | 520.6 | 547.6 |
| EBITDA 1 | 70.81 | 61.98 | 76.96 | 80.2 | 73.34 | 59.96 | 83.36 |
| EBIT 1 | 52.29 | 44.82 | 61.18 | 65.25 | 58.7 | 44.8 | 59.49 |
| Net income 1 | 19.73 | 19.45 | 40.94 | 31.4 | 31.8 | 21.18 | 37.3 |
| Net Debt | 170.9 | 157 | 148 | 107 | - | - | - |
| Reference price 2 | 22.31 | 20.27 | 17.66 | 17.31 | 16.03 | 12.72 | 12.72 |
| Nbr of stocks (in thousands) | 46,290 | 46,371 | 46,724 | 46,950 | 46,563 | 46,097 | - |
| Announcement Date | 02/02/22 | 01/02/23 | 31/01/24 | 29/01/25 | 04/02/26 | - | - |
1USD in Million2USD
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 23.36x | 2.77x | 12.33x | 3.55% | 22.46B | |
| 45.95x | 6.04x | 22.26x | 0.58% | 19.55B | |
| 20.42x | 2.95x | 12.08x | 1.28% | 3.56B | |
| 12.45x | - | - | 2.63% | 2.09B | |
| -41.21x | 1.39x | 8.89x | -.--% | 1.9B | |
| 22.8x | - | - | 2.24% | 1.64B | |
| Average | 13.96x | 3.29x | 13.89x | 1.71% | 8.53B | |
| Weighted average by Cap. | 28.92x | 4.08x | 16.26x | 2.05% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CLB Stock
- HJ1 Stock
- Valuation Core Laboratories Inc.
Select your edition
All financial news and data tailored to specific country editions
